**Current stage:** Gate H COMPLETE / PASS; Gate I COMPLETE / PASS; Gate J COMPLETE / PASS; Gate K COMPLETE / PASS; K1 COMPLETE / PASS / CLOSED; K2 COMPLETE / PASS / CLOSED; K3 COMPLETE / PASS / CLOSED; K4 COMPLETE / PASS / CLOSED across all 10 sector packages; K5 COMPLETE / PASS / CLOSED; K-FINAL COMPLETE / PASS / CLOSED; sector-specific research layer = PORTFOLIO COVERAGE COMPLETE; PR #101 OPEN / DRAFT / UNMERGED



---

## K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `industrialsK4bScoringMethodology.ts`;
- `industrialsK4bScoringMethodology.test.ts`;
- `industrialsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_2_INDUSTRIALS_CAPITAL_GOODS_CHECKPOINT_B.md`;
- canonical router extended for PROJECT_EPC / CAPITAL_EQUIPMENT_ELECTRICAL / DEFENCE_AEROSPACE;
- registry maps all three profiles to INDUSTRIALS_CAPITAL_GOODS in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct growth and cash-flow contracts for EPC, capital equipment and defence;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 2 · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 2 failed tests and 49 passed.

Both failures were stale expectations created by legitimate prior state transitions:

1. `industrialsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED` after Checkpoint A had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.
2. `scoringProfileResolution.test.ts` still expected completed `IT_TECH` to fail closed to GENERAL. IT_TECH is now an implemented engine identity, so profile resolution correctly returns `IT_TECH` with `SECTOR_RULE`; its legacy ruleProfile remains GENERAL because specialised IT scoring is separately owned by the read-only K4B authority rather than the old GENERAL-derived database scaffold.

Only the tests were corrected. No runtime methodology, classification, score, recommendation, persistence, provider, scheduler, deployment or production behavior was changed.

Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = PROJECT_EPC / CAPITAL_EQUIPMENT_ELECTRICAL / DEFENCE_AEROSPACE;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- working-capital/cash-conversion evidence remains mandatory;
- PHARMA_V1 / BANK_NBFC / IT_TECH isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS = COMPLETE / PASS / CLOSED.**

K4 Package 3 — AUTO_COMPONENTS Checkpoint A is now IN PROGRESS.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A implementation — 22 September 2026

INDUSTRIALS_CAPITAL_GOODS is closed COMPLETE / PASS.

Added:
- `autoComponentsK4aMethodologyContract.ts`;
- `autoComponentsK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_3_AUTO_COMPONENTS_CHECKPOINT_A.md`.

Proposed subprofiles:
1. AUTO_OEM — M&M and TVSMOTOR references;
2. AUTO_COMPONENTS — MOTHERSON and SONACOMS references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- OEM and component economics remain separate;
- EV transition is exposure/risk/durability metadata, not an automatic third score;
- minimum 3 annual years / 8 quarters / 252 trading days;
- cash conversion and ROCE/ROIC are mandatory;
- capex-cycle context is mandatory;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 2 failed tests and 24 passed.

Both failures were stale registry expectations after the legitimate closure of earlier K4 packages:

1. the registry test still expected 9 packages in `K4_FROZEN_PENDING`; after IT_TECH and INDUSTRIALS_CAPITAL_GOODS are implemented, the correct count is 8;
2. the registry test still expected `PROJECT_EPC` to belong to a pending Industrials engine; INDUSTRIALS_CAPITAL_GOODS is now implemented, so the correct lifecycle is `IMPLEMENTED`.

Only regression expectations were updated. No AUTO methodology, routing, scoring, recommendation, production, persistence, provider, scheduler or deployment behavior changed.

AUTO_COMPONENTS Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A FINAL — 22 September 2026

Owner-local contract tests and TypeScript passed completely and the owner approved proceeding.

`AUTO_COMPONENTS_K4A_METHODOLOGY_V1` is now frozen with two subprofiles:
- AUTO_OEM;
- AUTO_COMPONENTS.

EV transition remains exposure/risk/durability metadata rather than a separate score.

Runtime activation remains OFF until Checkpoint B portability/isolation validation passes.

**AUTO_COMPONENTS Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `autoComponentsK4bScoringMethodology.ts`;
- `autoComponentsK4bScoringMethodology.test.ts`;
- `autoComponentsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_3_AUTO_COMPONENTS_CHECKPOINT_B.md`;
- canonical router extended for AUTO_OEM / AUTO_COMPONENTS coverage including tractors/farm equipment and tyres/rubber products;
- registry maps both profiles to AUTO_COMPONENTS in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct OEM vs component growth contracts;
- EV transition remains durability/risk metadata and never creates a second score;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- completed INDUSTRIALS_CAPITAL_GOODS preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 50 passed.

The single failure was a stale Checkpoint A expectation:
- `autoComponentsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED`;
- the contract had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.

Only the regression expectation was updated. No AUTO routing, scoring methodology, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

AUTO_COMPONENTS Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 3 · AUTO_COMPONENTS FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = AUTO_OEM / AUTO_COMPONENTS;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- EV transition = durability/risk/exposure metadata only;
- PHARMA_V1 / BANK_NBFC / IT_TECH / INDUSTRIALS_CAPITAL_GOODS isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 3 · AUTO_COMPONENTS = COMPLETE / PASS / CLOSED.**

K4 Package 4 — CHEMICALS_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A implementation — 22 September 2026

AUTO_COMPONENTS is closed COMPLETE / PASS.

Added:
- `chemicalsK4aMethodologyContract.ts`;
- `chemicalsK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_4_CHEMICALS_CHECKPOINT_A.md`.

Proposed subprofiles:
1. SPECIALTY_CHEMICALS — PIIND / SRF references; VINATIORGA control;
2. AGRO_FERTILISER — PIIND / DEEPAKFERT references;
3. COMMODITY_PROCESS_CHEMICALS — SRF / DEEPAKFERT references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 3 annual years / 8 quarters / 252 trading days;
- cycle-normalised growth, margin and ROCE interpretation;
- capacity/utilisation must be reconciled with return on capital;
- feedstock/global pricing context mandatory where material;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 2 failed tests and 24 passed.

Both failures were stale registry lifecycle expectations after AUTO_COMPONENTS was legitimately promoted to IMPLEMENTED:
1. pending K4 package count was still hard-coded as 8, but the correct current count is 7;
2. AUTO_OEM was still expected to belong to a pending AUTO_COMPONENTS engine, while AUTO_COMPONENTS is now IMPLEMENTED.

To prevent the same avoidable failure after every subsequent K4 package, the registry lifecycle test was improved rather than merely changing 8 → 7:
- total registry entries must remain 12;
- excluding inherited PHARMA_V1 and BANK_NBFC, exactly 10 K4 packages must exist;
- each K4 package must be either IMPLEMENTED or K4_FROZEN_PENDING.

AUTO_OEM lifecycle expectation was updated to IMPLEMENTED.

No Chemicals methodology, routing, scoring, recommendation, persistence, provider, production, scheduler or deployment behavior changed.

CHEMICALS_V1 Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local contract tests and TypeScript passed completely and the owner approved proceeding.

`CHEMICALS_V1_K4A_METHODOLOGY_V1` is now frozen with three subprofiles:
- SPECIALTY_CHEMICALS;
- AGRO_FERTILISER;
- COMMODITY_PROCESS_CHEMICALS.

Runtime activation remains OFF until Checkpoint B portability/isolation validation passes.

**CHEMICALS_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `chemicalsK4bScoringMethodology.ts`;
- `chemicalsK4bScoringMethodology.test.ts`;
- `chemicalsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_4_CHEMICALS_CHECKPOINT_B.md`;
- canonical router extended for SPECIALTY_CHEMICALS / AGRO_FERTILISER / COMMODITY_PROCESS_CHEMICALS;
- registry maps all three profiles to CHEMICALS_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct growth contracts for specialty, agro/fertiliser and commodity/process chemicals;
- cycle normalization required;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- completed INDUSTRIALS_CAPITAL_GOODS preserved;
- completed AUTO_COMPONENTS preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 51 passed.

The single failure was a stale Checkpoint A expectation:
- `chemicalsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED`;
- the contract had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.

Only the regression expectation was updated. No Chemicals routing, scoring methodology, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

CHEMICALS_V1 Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 4 · CHEMICALS_V1 FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = SPECIALTY_CHEMICALS / AGRO_FERTILISER / COMMODITY_PROCESS_CHEMICALS;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- cycle normalization = mandatory;
- PHARMA_V1 / BANK_NBFC / prior K4 engine isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 4 · CHEMICALS_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 5 — HEALTHCARE_SERVICES_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A implementation — 22 September 2026

CHEMICALS_V1 is closed COMPLETE / PASS.

Added:
- `healthcareServicesK4aMethodologyContract.ts`;
- `healthcareServicesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_5_HEALTHCARE_SERVICES_CHECKPOINT_A.md`.

Initial scope intentionally contains one subprofile:
- HOSPITAL_OPERATORS — MAXHEALTH / NH / MEDANTA / YATHARTH references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- diagnostics are explicitly excluded from hospital scoring and must fail review pending separate methodology authority;
- minimum 3 annual years / 8 quarterly observations / 252 trading days;
- hospital operating evidence includes occupancy, ARPOB/equivalent and bed-ramp context where disclosed;
- bed additions must reconcile with ramp and ROCE;
- cash conversion must reconcile with capex/receivables;
- unknown/non-hospital Healthcare identity → METHOD_NOT_AVAILABLE / review;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 1 failed test and 26 passed.

The single failure was a stale registry lifecycle expectation:
- `SPECIALTY_CHEMICALS` was still expected to belong to CHEMICALS_V1 with lifecycle `K4_FROZEN_PENDING`;
- CHEMICALS_V1 had already been closed and promoted to `IMPLEMENTED`.

Only the regression expectation was updated. No Healthcare Services methodology, routing, scoring, recommendation, persistence, provider, production, scheduler or deployment behavior changed.

HEALTHCARE_SERVICES_V1 Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed. The hospital-only initial methodology is frozen.

From this checkpoint onward, K4 regression tests must avoid stale lifecycle assumptions:
- completed engines are asserted as IMPLEMENTED;
- only the active package may be K4_FROZEN_PENDING;
- package-count invariants remain dynamic;
- no test may retain a pre-approval or pre-closure expected state after the state transition is committed.

**HEALTHCARE_SERVICES_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `healthcareServicesK4bScoringMethodology.ts`;
- `healthcareServicesK4bScoringMethodology.test.ts`;
- `healthcareServicesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_5_HEALTHCARE_SERVICES_CHECKPOINT_B.md`;
- registry maps `HOSPITAL` to HEALTHCARE_SERVICES_V1 in validation-pending state;
- diagnostics remain deliberately unmapped from the hospital engine.

Deterministic scoring:
- ten dimensions totaling 100;
- hospital-specific operating durability evidence;
- no missing-input renormalization;
- diagnostics → REVIEW_REQUIRED / separate methodology required;
- symbol-independent methodology;
- score/recommendation persistence remain OFF.

Regression policy improvement:
- the current package test is lifecycle-stable and valid both before and after promotion;
- no stale pre-approval/pre-closure expectation is intentionally carried into this B suite;
- completed packages are asserted only in their durable IMPLEMENTED state.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- IT_TECH / INDUSTRIALS_CAPITAL_GOODS / AUTO_COMPONENTS / CHEMICALS_V1 preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint B precision correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 52 passed.

The failure was not a stale lifecycle expectation and not a methodology error. JavaScript floating-point arithmetic produced `73.99999999999999` for a weighted score that is mathematically 74.

Correction:
- deterministic K4B scorers now apply a stable output rounding step with `Number(value.toFixed(6))` to the final weighted overall score;
- the same stable precision rule was applied proactively to IT_TECH, INDUSTRIALS_CAPITAL_GOODS, AUTO_COMPONENTS and CHEMICALS_V1 scorers to prevent the same numerical artifact from recurring.

No weights, dimensions, methodology, evidence rules, routing, recommendation logic, persistence, provider behavior, production behavior, scheduler or deployment behavior changed.

HEALTHCARE_SERVICES_V1 Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported authority = HOSPITAL;
- diagnostics remain deliberately outside hospital scoring;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- PHARMA_V1 / BANK_NBFC / prior K4 engine isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- stable weighted-score precision = 6 decimals;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 5 · HEALTHCARE_SERVICES_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 6 — FIN_SERVICES_NON_LENDER Checkpoint A is now IN PROGRESS.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint A implementation — 22 September 2026

HEALTHCARE_SERVICES_V1 is closed COMPLETE / PASS.

Added:
- `finServicesNonLenderK4aMethodologyContract.ts`;
- `finServicesNonLenderK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_6_FIN_SERVICES_NON_LENDER_CHECKPOINT_A.md`.

Proposed mandatory subprofiles:
1. CAPITAL_MARKETS_AMC — NAM-INDIA / HDFCAMC / ANGELONE / CAMS;
2. INSURANCE — STARHEALTH;
3. FINTECH_PLATFORM — PAYTM / POLICYBZR.

Key methodology locks proposed:
- non-lender Financial Services must not inherit BANK_NBFC lender metrics or thresholds;
- no NPA / CET1 / deposit-growth methodology leakage;
- Nifty Bank is not a benchmark authority for this package;
- subprofile-specific evidence and valuation are mandatory;
- insurance claims/reserving evidence cannot be replaced by generic margins;
- fintech growth cannot override cash burn/unit economics;
- cross-subprofile peer percentiles prohibited;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active for this package and subsequent K4 packages.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed. The three-subprofile non-lender Financial Services methodology is frozen.

Frozen subprofiles:
- CAPITAL_MARKETS_AMC;
- INSURANCE;
- FINTECH_PLATFORM.

Hard separation from BANK_NBFC remains mandatory.

**FIN_SERVICES_NON_LENDER Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `finServicesNonLenderK4bScoringMethodology.ts`;
- `finServicesNonLenderK4bScoringMethodology.test.ts`;
- `finServicesNonLenderK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_6_FIN_SERVICES_NON_LENDER_CHECKPOINT_B.md`;
- canonical router now uses CAPITAL_MARKETS_AMC / INSURANCE / FINTECH_PLATFORM;
- NBFC_LENDING remains separate under BANK_NBFC;
- registry maps all three non-lender profiles to FIN_SERVICES_NON_LENDER in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- subprofile-specific evidence contracts;
- no missing-input renormalization;
- no lender-metric inheritance;
- symbol-independent methodology;
- unknown/lender Industry → METHOD_NOT_AVAILABLE for this engine.

Regression policy:
- Checkpoint A test was proactively aligned before B validation;
- current-package isolation is lifecycle-stable before/after promotion;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 and BANK_NBFC isolated;
- K4 Packages 1–5 preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint B routing regression correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 53 passed.

The failure was a legacy profile-code expectation in `researchProfileRouting.test.ts`:
- old expected `CAPITAL_MARKET_FINANCIAL` while the frozen Package 6 profile is `CAPITAL_MARKETS_AMC`;
- old expected `DIGITAL_PLATFORM` while the frozen Package 6 profile is `FINTECH_PLATFORM`.

Only the regression expectations were updated to the frozen K4 profile identities. No routing logic, scoring methodology, lender separation, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

FIN_SERVICES_NON_LENDER Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = CAPITAL_MARKETS_AMC / INSURANCE / FINTECH_PLATFORM;
- lender methodology inheritance = prohibited;
- NBFC_LENDING remains under BANK_NBFC;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- six-decimal stable weighted score precision retained;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 6 · FIN_SERVICES_NON_LENDER = COMPLETE / PASS / CLOSED.**

K4 Package 7 — METALS_COMMODITIES Checkpoint A is now IN PROGRESS.


---

## K4 Package 7 · METALS_COMMODITIES · Checkpoint A implementation — 22 September 2026

FIN_SERVICES_NON_LENDER is closed COMPLETE / PASS.

Added:
- `metalsCommoditiesK4aMethodologyContract.ts`;
- `metalsCommoditiesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_7_METALS_COMMODITIES_CHECKPOINT_A.md`.

K1 open question resolved:
- METALS_COMMODITIES requires two methodology curves:
  1. STEEL_FERROUS — JINDALSTEL reference;
  2. NON_FERROUS_DIVERSIFIED_METALS — HINDALCO / HINDZINC references.

Key locks proposed:
- commodity exposure metadata mandatory;
- minimum 5 annual years / 12 quarters / 252 trading days;
- through-cycle normalization mandatory;
- cost curve/input integration context mandatory;
- leverage assessed at mid-cycle;
- spot P/E cannot be the sole valuation anchor;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 7 · METALS_COMMODITIES · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`METALS_COMMODITIES_K4A_METHODOLOGY_V1` is frozen with:
- STEEL_FERROUS;
- NON_FERROUS_DIVERSIFIED_METALS.

**METALS_COMMODITIES Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 7 · METALS_COMMODITIES · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `metalsCommoditiesK4bScoringMethodology.ts`;
- `metalsCommoditiesK4bScoringMethodology.test.ts`;
- `metalsCommoditiesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_7_METALS_COMMODITIES_CHECKPOINT_B.md`;
- canonical router extended for STEEL_FERROUS / NON_FERROUS_DIVERSIFIED_METALS;
- registry maps both profiles to METALS_COMMODITIES in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory commodity exposure metadata readiness gate;
- through-cycle normalization;
- mid-cycle leverage assessment;
- distinct steel vs non-ferrous growth contracts;
- spot P/E cannot be sole valuation anchor;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–6 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 7 · METALS_COMMODITIES FINAL CLOSURE — 22 September 2026

Owner-local Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = STEEL_FERROUS / NON_FERROUS_DIVERSIFIED_METALS;
- commodity-exposure metadata = mandatory readiness gate;
- through-cycle normalization = mandatory;
- spot P/E as sole valuation anchor = prohibited;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 7 · METALS_COMMODITIES = COMPLETE / PASS / CLOSED.**

K4 Package 8 — CONSUMER_FMCG Checkpoint A is now IN PROGRESS.


---

## K4 Package 8 · CONSUMER_FMCG · Checkpoint A implementation — 22 September 2026

METALS_COMMODITIES is closed COMPLETE / PASS.

Added:
- `consumerFmcgK4aMethodologyContract.ts`;
- `consumerFmcgK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_8_CONSUMER_FMCG_CHECKPOINT_A.md`.

Initial profile:
- BRANDED_CONSUMER_FMCG.

Reference anchors:
- HINDUNILVR;
- VBL;
- LTFOODS;
- RADICO as alcohol-specific risk control.

Key methodology locks proposed:
- one initial branded/staples curve per K1;
- Industry selects methodology; Sector alone cannot;
- product/category metadata mandatory;
- alcohol excise/regulatory exposure is explicit risk metadata, not a separate universal score curve;
- minimum 3 annual years / 8 quarters / 252 trading days;
- volume/price/mix context where disclosed;
- raw-material inflation read with margin history;
- working capital and cash conversion are core evidence;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain profile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 8 · CONSUMER_FMCG · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`CONSUMER_FMCG_K4A_METHODOLOGY_V1` is frozen with one initial profile:
- BRANDED_CONSUMER_FMCG.

Product/category metadata remains mandatory. Alcohol remains an excise/regulatory risk variant rather than a separate universal score curve.

**CONSUMER_FMCG Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 8 · CONSUMER_FMCG · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `consumerFmcgK4bScoringMethodology.ts`;
- `consumerFmcgK4bScoringMethodology.test.ts`;
- `consumerFmcgK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_8_CONSUMER_FMCG_CHECKPOINT_B.md`;
- canonical router extended for BRANDED_CONSUMER_FMCG;
- registry maps the profile to CONSUMER_FMCG in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory PRODUCT_CATEGORY_METADATA readiness gate;
- one branded/staples scoring curve per K1;
- alcohol remains explicit excise/regulatory risk metadata, not a separate universal curve;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–7 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 8 · CONSUMER_FMCG FINAL CLOSURE — 22 September 2026

Owner-local Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported profile = BRANDED_CONSUMER_FMCG;
- product/category metadata = mandatory readiness gate;
- alcohol = explicit excise/regulatory risk metadata, not a separate score curve;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 8 · CONSUMER_FMCG = COMPLETE / PASS / CLOSED.**

K4 Package 9 — OIL_GAS_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 9 · OIL_GAS_V1 · Checkpoint A implementation — 22 September 2026

CONSUMER_FMCG is closed COMPLETE / PASS.

Added:
- `oilGasK4aMethodologyContract.ts`;
- `oilGasK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_9_OIL_GAS_CHECKPOINT_A.md`.

Mandatory K1 subprofiles preserved:
1. UPSTREAM_E_AND_P — ONGC;
2. MIDSTREAM_CITY_GAS — GAIL / MGL / IGL;
3. INTEGRATED_REFINING_PETCHEM — RELIANCE as mixed-business control, not sole authority.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 5 annual years / 12 quarterly cycle observations / 252 trading days;
- commodity and refining-cycle normalization mandatory;
- reserve/volume/throughput context required by subprofile;
- administered pricing/tax context required where material;
- energy-transition risk explicit;
- mixed-business controls cannot override pure-play economics;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 9 · OIL_GAS_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`OIL_GAS_V1_K4A_METHODOLOGY_V1` is frozen with:
- UPSTREAM_E_AND_P;
- MIDSTREAM_CITY_GAS;
- INTEGRATED_REFINING_PETCHEM.

**OIL_GAS_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 9 · OIL_GAS_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `oilGasK4bScoringMethodology.ts`;
- `oilGasK4bScoringMethodology.test.ts`;
- `oilGasK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_9_OIL_GAS_CHECKPOINT_B.md`;
- canonical router extended for UPSTREAM_E_AND_P / MIDSTREAM_CITY_GAS / INTEGRATED_REFINING_PETCHEM;
- registry maps all three profiles to OIL_GAS_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory SUBPROFILE_OPERATING_CONTEXT readiness gate;
- through-cycle commodity/refining normalization;
- distinct subprofile growth contracts;
- RELIANCE remains a mixed-business control, not sole methodology authority;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–8 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 9 · OIL_GAS_V1 FINAL CLOSURE — 22 September 2026

Owner-local Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = UPSTREAM_E_AND_P / MIDSTREAM_CITY_GAS / INTEGRATED_REFINING_PETCHEM;
- mandatory operating-context readiness gate retained;
- commodity/refining-cycle normalization mandatory;
- RELIANCE remains mixed-business control rather than sole authority;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 9 · OIL_GAS_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 10 — POWER_RENEWABLES_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 10 · POWER_RENEWABLES_V1 · Checkpoint A implementation — 22 September 2026

OIL_GAS_V1 is closed COMPLETE / PASS.

Added:
- `powerRenewablesK4aMethodologyContract.ts`;
- `powerRenewablesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_10_POWER_RENEWABLES_CHECKPOINT_A.md`.

Mandatory K1 subprofiles preserved:
1. REGULATED_NETWORK — POWERGRID;
2. GENERATION_INTEGRATED_UTILITY — TATAPOWER / NHPC;
3. RENEWABLE_IPP — ACMESOLAR / KPIGREEN subject to identity review.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 5 annual years / 12 operating quarters / 252 trading days;
- tariff/regulatory context required where material;
- fuel/resource variability normalized for generation;
- PPA/offtaker/DISCOM quality required for contracted assets;
- leverage and refinancing sensitivity are core evidence;
- capacity growth cannot override cash-flow/execution weakness;
- transmission/grid-evacuation constraints are explicit risks;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 10 · POWER_RENEWABLES_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`POWER_RENEWABLES_V1_K4A_METHODOLOGY_V1` is frozen with:
- REGULATED_NETWORK;
- GENERATION_INTEGRATED_UTILITY;
- RENEWABLE_IPP.

**POWER_RENEWABLES_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 10 · POWER_RENEWABLES_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `powerRenewablesK4bScoringMethodology.ts`;
- `powerRenewablesK4bScoringMethodology.test.ts`;
- `powerRenewablesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_10_POWER_RENEWABLES_CHECKPOINT_B.md`;
- canonical router extended for REGULATED_NETWORK / GENERATION_INTEGRATED_UTILITY / RENEWABLE_IPP;
- registry maps all three profiles to POWER_RENEWABLES_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory TARIFF_PPA_OFFTAKER_GRID_CONTEXT readiness gate;
- distinct regulated-network / generation-utility / renewable-IPP growth contracts;
- leverage/refinancing is core evidence;
- project/grid/offtaker risk cannot be bypassed by capacity growth;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- Packages 1–9 are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–9 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion and formal K4 closure occur only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 10 · POWER_RENEWABLES_V1 FINAL CLOSURE — 22 September 2026

Owner-local final Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = REGULATED_NETWORK / GENERATION_INTEGRATED_UTILITY / RENEWABLE_IPP;
- tariff/PPA/offtaker/grid context = mandatory readiness gate;
- leverage/refinancing = core evidence;
- capacity growth cannot bypass cash-flow, execution, counterparty or grid-risk evidence;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 10 · POWER_RENEWABLES_V1 = COMPLETE / PASS / CLOSED.**

---

## Gate K4 FINAL CLOSURE — 22 September 2026

All ten K4 packages are now COMPLETE / PASS / CLOSED:

1. IT_TECH
2. INDUSTRIALS_CAPITAL_GOODS
3. AUTO_COMPONENTS
4. CHEMICALS_V1
5. HEALTHCARE_SERVICES_V1
6. FIN_SERVICES_NON_LENDER
7. METALS_COMMODITIES
8. CONSUMER_FMCG
9. OIL_GAS_V1
10. POWER_RENEWABLES_V1

K4 global invariants preserved:
- Industry is the minimum micro-methodology selector;
- Sector is macro context only;
- no ticker-specific runtime methodology;
- no missing-input renormalization;
- no cross-subprofile leakage;
- deterministic read-only scoring;
- golden Pharma controls preserved;
- universal Research shell preserved;
- no score persistence;
- no recommendation persistence;
- no provider calls during K4 builds;
- no production mutation/migration;
- no scheduler change;
- no deployment;
- PR #101 remains OPEN / DRAFT / UNMERGED;
- no automatic trading.

**Gate K4 = COMPLETE / PASS / CLOSED.**

Next planned stage: **K5 — whole-portfolio coexistence and routing validation**.


---

## Gate K5 · Cross-Sector Isolation & Whole-Portfolio Validation implementation — 22 September 2026

Gate K4 is closed COMPLETE / PASS.

K5 implementation added:
- `k5CrossSectorValidation.ts`;
- `k5CurrentPortfolioRoutingSnapshot.ts` containing the frozen 238-equity K1 routing fixture;
- `k5CrossSectorIsolation.test.ts`;
- `k5WholePortfolioRouting.test.ts`;
- `k5RecommendationPortability.test.ts`;
- `docs/PortfolioAI_GATE_K_K5_CROSS_SECTOR_WHOLE_PORTFOLIO_VALIDATION.md`.

K5 validation design:
- registry-driven complete ordered pairwise engine isolation matrix;
- unique profile ownership;
- foreign methodology/benchmark/valuation/recommendation authority retrieval prohibited;
- all ten K4 engines required to remain IMPLEMENTED;
- every frozen current-portfolio row required to end in an explicit research architecture state;
- synthetic future-stock portability fixture for every currently SUPPORTED profile;
- unsupported sectors → METHODOLOGY_NOT_AVAILABLE;
- missing/conflicting classification → REVIEW_REQUIRED;
- no nearest-looking sector fallback;
- pending NBFC_LENDING and DIAGNOSTICS remain fail-closed;
- universal Research shell preserved;
- TORNTPHARM/AUROPHARMA golden controls preserved.

Recommendation portability study:
- universal semantics remain portable;
- numeric threshold portability = NOT_ESTABLISHED;
- pre-declared falsification tests encoded before any future portability claim;
- K5 introduces NO universal numeric recommendation thresholds;
- sector/profile-specific numeric policy still requires evidence and owner approval.

Safety unchanged:
- provider calls = 0;
- production mutation/migration = NO;
- score/recommendation persistence = OFF;
- position sizing = OFF;
- scheduler changes = NO;
- deployment = NO;
- PR merge = NO;
- automatic trading = NO.

**K5 status = IMPLEMENTED / LOCAL VALIDATION PENDING.**


---

## Gate K5 · Consolidated validation checkpoint — 22 September 2026

Current K5 candidate implementation was audited against the canonical Gate K plan before any additional methodology work.

Audit result:
- K5 is correctly implemented as a confirmation gate, not a methodology-building gate;
- 12 registered engine families imply 132 ordered pairwise isolation checks;
- methodology / benchmark / valuation / recommendation authority lookups are registry-owned and cross-engine lookup fails closed;
- every frozen K1 portfolio row is required to resolve to SUPPORTED_ENGINE / METHODOLOGY_NOT_AVAILABLE / REVIEW_REQUIRED / NOT_APPLICABLE;
- supported future-stock routing is classification-driven rather than ticker-driven;
- NBFC_LENDING and DIAGNOSTICS remain intentionally fail-closed pending dedicated authority;
- universal Research shell continuity is explicitly asserted;
- recommendation universal semantics are retained while numeric-threshold portability remains NOT_ESTABLISHED;
- pre-declared portability falsification tests are encoded before any future universal-threshold claim;
- no universal numeric recommendation threshold was introduced.

Consolidation improvement:
- added `scripts/k5-validate-cross-sector.sh`;
- this is now the single owner-local K5 closure command;
- it runs the full K5 isolation, routing, recommendation-portability, registry, profile-routing, scoring-resolution, K2 recommendation-safety, Research-workspace regression set, then TypeScript;
- no stale pre-approval / pre-promotion lifecycle assertion was added.

CI observation:
- initial K5 GitHub Architecture Guard run ended before any job step was created/executed, so it does not demonstrate a K5 test failure;
- separate Vercel status failed on a build-rate-limit condition;
- no runtime methodology or safety change was made in response.

Safety remains unchanged:
- provider calls = 0;
- production mutation/migration = NO;
- score persistence = OFF;
- recommendation persistence = OFF;
- position sizing = OFF;
- scheduler changes = NO;
- deployment = NO;
- PR merge = NO;
- automatic trading = NO.

**K5 status remains IMPLEMENTED / LOCAL VALIDATION PENDING.**

Required owner-local closure command:

```bash
git pull
bash scripts/k5-validate-cross-sector.sh
```


---

## Gate K5 · Chat rollover checkpoint — 22 September 2026

The owner explicitly instructed that K5 is now to be executed and supplied the canonical Gate K plan for continuity.

Canonical K5 scope reaffirmed:
- K5 is a confirmation gate, not a new methodology-building stage;
- complete registry-driven cross-sector isolation must be validated;
- every registered engine pair must remain isolated for methodology, benchmark, valuation, durability/recommendation authority and fallback behavior;
- future supported stocks must route by canonical classification without ticker-specific logic;
- unsupported sectors must fail safely to METHODOLOGY_NOT_AVAILABLE;
- conflicting or missing canonical classification must fail to REVIEW_REQUIRED rather than use a nearest-looking fallback;
- the universal Research workspace must remain shared across all engines;
- recommendation-policy portability must be evaluated using pre-declared falsification tests rather than assumed.

Current K5 repository state at chat rollover:
- K5 implementation is already present;
- consolidated K5 validation script exists at `scripts/k5-validate-cross-sector.sh`;
- frozen 238-equity K1 routing snapshot is part of K5 validation;
- complete cross-sector isolation/routing/recommendation-portability tests are present;
- universal numeric recommendation-threshold portability remains NOT_ESTABLISHED;
- no new methodology or threshold policy was introduced during the latest inspection;
- no provider refresh was authorized or performed.

Current owner-local closure command remains:

```bash
git pull
bash scripts/k5-validate-cross-sector.sh
```

K5 must not be marked COMPLETE / PASS / CLOSED until that consolidated owner-local validation passes and the result is recorded.

Permanent safety boundaries remain:
- no production mutation/migration;
- no score persistence;
- no recommendation persistence;
- no provider refresh unless explicitly approved;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

PR #101 remains OPEN / DRAFT / UNMERGED.

**Current checkpoint: K5 IMPLEMENTED / LOCAL VALIDATION PENDING.**


---

## Gate K5 · First consolidated validation correction — 22 September 2026

Owner-local consolidated K5 validation result:
- 8 test files executed;
- 7 passed / 1 failed;
- 56 tests passed / 1 failed;
- the only failure was the synthetic future-stock portability case for `AUTO_OEM`.

Root cause:
- the K5 synthetic future-stock fixture used sector text `Automobile & Auto Components`;
- the frozen canonical routing identity is `Automobile and Auto Components`;
- the router correctly remained fail-closed because the synthetic fixture did not match the canonical classification key;
- the frozen 238-equity whole-portfolio routing test passed;
- the dedicated AUTO routing regression already passed;
- therefore this was a stale/non-canonical synthetic fixture, not a runtime methodology or routing defect.

Correction:
- updated only the two synthetic AUTO future-stock fixtures in `k5CrossSectorValidation.ts`;
- `AUTO_OEM` fixture now uses canonical sector `Automobile and Auto Components`;
- `AUTO_COMPONENTS` fixture now uses the same canonical sector identity;
- no router broadening was introduced;
- no methodology, benchmark, valuation, recommendation authority, lifecycle, persistence, provider, scheduler, deployment or production behavior changed.

K5 remains **IMPLEMENTED / LOCAL VALIDATION PENDING** until the consolidated suite is rerun.

Required rerun:

```bash
git pull
bash scripts/k5-validate-cross-sector.sh
```


---

## Gate K5 · FINAL CLOSURE — 22 September 2026

Owner-local consolidated K5 validation rerun passed completely after the non-canonical AUTO synthetic future-stock fixture was corrected.

Final K5 validation outcome:
- consolidated runner `scripts/k5-validate-cross-sector.sh` = PASS;
- cross-sector isolation = PASS;
- whole-portfolio routing = PASS;
- future-stock portability = PASS;
- recommendation portability study = PASS;
- registry regression = PASS;
- research profile routing = PASS;
- scoring profile resolution = PASS;
- K2 recommendation safety = PASS;
- universal Research workspace contract = PASS;
- TypeScript = PASS.

K5 exit conditions are satisfied:
- all 12 registered engine families coexist without methodology / benchmark / valuation / recommendation authority leakage;
- complete registry-driven ordered pairwise isolation passes;
- all ten K4 engines remain in durable IMPLEMENTED state;
- the frozen 238-equity K1 portfolio routing snapshot resolves only to explicit supported / unavailable / review / not-applicable architecture states;
- supported future stocks route by canonical classification without ticker-specific methodology;
- unsupported sectors fail safely to `METHODOLOGY_NOT_AVAILABLE`;
- missing/conflicting classification fails safely to `REVIEW_REQUIRED`;
- no nearest-looking fallback exists;
- the universal Research workspace contract remains intact;
- TORNTPHARM/AUROPHARMA golden controls remain stable;
- universal recommendation semantics are portable;
- universal numeric recommendation thresholds are NOT established as portable and must not be assumed;
- any future sector/profile-specific numeric recommendation authority still requires evidence and owner approval.

Permanent safety boundaries remain unchanged:
- no production mutation/migration;
- no score persistence;
- no recommendation persistence;
- no provider refresh unless explicitly approved;
- no position sizing activation;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

PR #101 remains OPEN / DRAFT / UNMERGED.

**Gate K5 = COMPLETE / PASS / CLOSED.**

Next and final hard-capped Gate K stage: **K-FINAL — Portfolio Sector-Coverage Closure**.


---

## Gate K-FINAL · Portfolio Sector-Coverage Closure implementation — 22 September 2026

K5 is closed COMPLETE / PASS.

K-FINAL has been implemented as the final Gate K confirmation/closure package only. No new methodology or threshold policy was introduced.

Added:
- `src/features/research/kFinalPortfolioCoverage.ts`;
- `src/features/research/kFinalPortfolioCoverage.test.ts`;
- `scripts/k-final-validate-portfolio-coverage.sh`;
- `docs/PortfolioAI_GATE_K_FINAL_PORTFOLIO_SECTOR_COVERAGE_CLOSURE.md`.

Portfolio-wide closure matrix:
- generated from the frozen 238-equity K1/K5 routing snapshot;
- every holding resolves to exactly one architecture state:
  - ARCHITECTURE_READY;
  - METHODOLOGY_NOT_AVAILABLE;
  - REVIEW_REQUIRED;
  - NOT_APPLICABLE;
- supported holdings are deliberately marked score/recommendation EVIDENCE_DEPENDENT rather than falsely claiming evidence completeness;
- unsupported methodology fails closed to SCORE_NOT_COMPUTABLE / RECOMMENDATION_NOT_COMPUTABLE;
- unresolved/conflicting classification remains REVIEW_REQUIRED.

K-FINAL acceptance coverage includes:
- explicit architecture state for every frozen current holding;
- no cross-sector methodology leakage;
- future-stock portability;
- universal Research workspace continuity;
- fail-closed missing evidence;
- N/A distinct from missing;
- recommendation safety;
- complete registry-driven isolation;
- stable Pharma golden controls;
- unsupported-sector fail-safe behavior;
- score persistence OFF;
- recommendation persistence OFF;
- position sizing OFF;
- Gate K AI interpretation activation OFF;
- production mutation/migration OFF;
- deployment OFF;
- PR merge OFF;
- automatic trading OFF.

Consolidated owner-local validation command:

```bash
git pull
bash scripts/k-final-validate-portfolio-coverage.sh
```

The K-FINAL suite is lifecycle-stable and does not reintroduce stale pre-approval/pre-promotion expectations.

Permanent safety boundaries remain unchanged:
- no production mutation/migration;
- no score persistence;
- no recommendation persistence;
- no provider refresh unless explicitly approved;
- no position sizing activation;
- no AI interpretation activation under Gate K;
- no portfolio mutation;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

**K-FINAL status = IMPLEMENTED / LOCAL VALIDATION PENDING.**

Gate K must not be marked COMPLETE / PASS until the consolidated K-FINAL command passes and the result is recorded.


---

## Gate K-FINAL · FINAL CLOSURE — 22 September 2026

Owner-local consolidated K-FINAL validation passed completely.

Final validation outcome:
- `scripts/k-final-validate-portfolio-coverage.sh` = PASS;
- K-FINAL portfolio coverage closure test = PASS;
- K5 cross-sector isolation = PASS;
- K5 whole-portfolio routing = PASS;
- K5 future-stock portability = PASS;
- K5 recommendation portability = PASS;
- K3 BANK_NBFC N/A semantics = PASS;
- K2 recommendation safety = PASS;
- Pharma read-only downstream safety = PASS;
- universal Research workspace regression = PASS;
- TypeScript = PASS.

Gate K final acceptance:
1. every frozen current holding has an explicit research-engine architecture state — PASS;
2. no stock silently inherits unrelated methodology — PASS;
3. supported sectors remain portable to future stocks — PASS;
4. all engines share the universal Research workspace — PASS;
5. missing mandatory evidence fails closed — PASS;
6. N/A remains distinct from missing — PASS;
7. recommendation safety semantics remain preserved — PASS;
8. cross-sector methodology isolation passes — PASS;
9. golden control outputs remain stable — PASS;
10. unsupported sectors safely report METHODOLOGY_NOT_AVAILABLE — PASS;
11. score persistence remains OFF — PASS;
12. recommendation persistence remains OFF — PASS;
13. position sizing remains OFF — PASS;
14. AI interpretation activation remains OFF under Gate K — PASS;
15. production mutation/migration remains OFF — PASS;
16. deployment remains OFF — PASS;
17. PR merge remains OFF — PASS;
18. automatic trading remains OFF — PASS.

Closure interpretation:
- portfolio classification + methodology architecture coverage is now complete/fail-closed;
- this does not claim all 238 holdings already have full evidence, computable scores or eligible recommendations;
- supported holdings may remain evidence-dependent;
- unsupported or unresolved holdings remain explicitly unavailable/review-required.

Permanent safety boundaries remain unchanged:
- no production mutation/migration;
- no provider refresh unless separately approved;
- no score persistence;
- no recommendation persistence;
- no position sizing activation;
- no AI interpretation activation under Gate K;
- no portfolio mutation;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

**Gate K-FINAL = COMPLETE / PASS / CLOSED.**

**Gate K = COMPLETE / PASS.**

**Sector-specific research layer = PORTFOLIO COVERAGE COMPLETE.**

PR #101 remains OPEN / DRAFT / UNMERGED pending a separate explicit owner decision.


---

## Post-Gate-K architecture / roadmap audit — 23 September 2026

A detailed post-K reconciliation was completed against:
- PortfolioAI Master Blueprint;
- Research & Intelligence Architecture;
- Integration & Execution Plan;
- Requirements Register;
- living Development Status;
- R3/R4 routing plan;
- actual H→K implementation and closure records.

Audit document:
- `docs/PortfolioAI_POST_GATE_K_ARCHITECTURE_AND_ROADMAP_AUDIT.md`.

Primary conclusion:
- **no Gate L or Gate M is currently required or canonically defined**;
- creating L/M now would duplicate the existing R-roadmap and confuse methodology completion with evidence/execution breadth;
- Gate K has effectively superseded/completed the old **R4 generic sector/profile Research contract** objective.

What Gate K completed:
- portfolio-coverage/fail-closed research methodology architecture for the frozen Gate-K scope;
- 12 registered engine families;
- one universal Research workspace;
- industry/business-model methodology selection;
- future-stock portability;
- cross-sector isolation;
- unsupported/review-required fail-safe behavior;
- deterministic sector scoring methodology authorities;
- universal recommendation semantics, without assuming portable numeric thresholds.

What remains materially incomplete:
- R3 portfolio-wide fundamental/research evidence breadth;
- R5 portfolio-wide historical market evidence;
- R6 actual company-specific deterministic scoring execution;
- sector/profile numeric recommendation policy calibration where still pending;
- R7 recommendation + position-sizing rollout;
- R8 Core Health / Portfolio Fit / Risk / Exit engines;
- R9 Movement / meaningful-change detection;
- R10 Combined Action Center;
- R11 general scheduled maintenance;
- R12 optional AI Investment Committee.

Recommended consolidation:
- Program A = R3 + R5 Evidence Coverage;
- Program B = R6 + recommendation calibration + R7 Deterministic Portfolio Intelligence;
- Program C = R8 + R9 + R10 Portfolio Decision Engines;
- Program D = R11 + R12 Operations & Optional AI.

Immediate governance recommendation:
- do not add another large development chain to PR #101;
- PR #101 remains OPEN / DRAFT / UNMERGED and currently carries a very large accumulated scope;
- freeze the Gate-K handoff and decide PR #101 disposition before beginning Program A on a clean branch;
- production/provider execution remains separately approval-gated.

Living Development Status was reconciled to reflect:
- Gate K COMPLETE / PASS;
- old R4 objective superseded/completed by H→K;
- next substantive work = R3 + R5 breadth, not Gate L/M.

**Post-K roadmap status: AUDITED / RECONCILED / OWNER REVIEW PENDING.**


---

## Post-Gate-K canonical forthcoming action plan — 23 September 2026

Canonical plan created:
- `docs/PortfolioAI_POST_GATE_K_FORTHCOMING_ACTION_PLAN.md`.

This file is now the required roadmap reference before any new post-K Program begins.

Mandatory review rule:
- before Program A, B, C or D, review the forthcoming action plan;
- review this cumulative handoff;
- inspect the current branch/PR/runtime state;
- confirm prerequisites and stale assumptions;
- create a bounded Program-specific plan;
- obtain separate owner approval for any provider, production, persistence, scheduler, deployment or merge action.

Frozen post-K Program sequence:
- **Program A — Evidence Coverage = R3 + R5**;
- **Program B — Deterministic Portfolio Intelligence = R6 + recommendation calibration + R7**;
- **Program C — Portfolio Decision Engines = R8 + R9 + R10**;
- **Program D — Operations & Optional AI = R11 + R12**.

Gate L / Gate M:
- not currently required;
- not canonically defined;
- must not be created merely to rename the remaining R-roadmap;
- a new letter Gate is justified only by a genuinely new architecture problem.

Immediate prerequisite before Program A implementation:
- freeze Gate-K state;
- explicitly decide PR #101 disposition / branch strategy;
- start substantive Program A work on a clean post-K branch after that strategy is frozen.

Current statuses:
- Gate K = COMPLETE / PASS;
- Program A = NOT STARTED;
- Program B = NOT STARTED;
- Program C = NOT STARTED;
- Program D = NOT STARTED;
- PR #101 = OPEN / DRAFT / UNMERGED.

Permanent safety boundaries remain unchanged:
- no production mutation/migration without explicit approval;
- no provider execution without explicit approval;
- no broad Trendlyne cohort without explicit approval;
- no Angel One history backfill without explicit approval;
- no score/recommendation/sizing persistence without explicit approval;
- no scheduler activation;
- no portfolio mutation;
- no deployment;
- no PR merge;
- no automatic trading.

**Post-K forthcoming action plan = CREATED / CANONICAL / REQUIRED BEFORE EACH PROGRAM.**


---

## Post-K Reconciliation Checkpoint PKR-1 / PKR-1B — 23 September 2026

Purpose:
- reconcile the live Research scoring path and regression suite with the already-closed Gate-K fail-closed architecture before Program A begins;
- this checkpoint did not start Program A and did not change any financial scoring methodology.

Implementation commits:
- PKR-1: `412e3e36a6f435675d4293c4678c54d0b4acea8e`
- PKR-1B: `f22b4efc8607102c51abadd46c62f362fd837084`

### PKR-1 corrections

- TypeScript-safe optional access added to BANK/NBFC profile-authority regression tests;
- stale pre-closure K4 lifecycle tests updated to durable `IMPLEMENTED` expectations;
- unsupported/pending methodology no longer falls through to a scoreable `GENERAL` profile;
- missing/conflicting classification remains `REVIEW_REQUIRED`;
- unsupported/pending methodology becomes `METHODOLOGY_NOT_AVAILABLE`;
- fail-closed states short-circuit before scoring-model/evidence queries;
- Research UI shows explicit blocked state instead of a generic score preview;
- cached score snapshots cannot override a newer fail-closed state;
- `BANK_NBFC` family lifecycle remains intentionally `RECONCILIATION_REQUIRED` because BANK is supported while NBFC_LENDING remains `PENDING_METHODOLOGY`;
- no BANK benchmark/valuation/recommendation leakage into NBFC.

### PKR-1B final live-scoring reconciliation

A second issue was identified during ChatGPT diff audit: completed K4 engines still retained `ruleProfile = GENERAL`, which could have allowed legacy GENERAL numeric previews even though their Gate-K methodologies are sector-specific.

PKR-1B introduced an explicit separation:

```text
Methodology state
AVAILABLE
METHODOLOGY_NOT_AVAILABLE
REVIEW_REQUIRED

Score-execution state
AVAILABLE
PENDING_ADAPTER
BLOCKED
```

Final behavior:
- PHARMA_V1 and supported BANK scoring: methodology AVAILABLE + score execution AVAILABLE;
- completed K4 engines: methodology AVAILABLE + score execution PENDING_ADAPTER;
- completed K4 engines retain their sector engine identity but select no GENERAL rule profile;
- routed and reviewed K4 assignments cannot bypass the guard;
- unsupported methodology: METHODOLOGY_NOT_AVAILABLE + BLOCKED;
- missing/conflicting classification: REVIEW_REQUIRED + BLOCKED;
- NBFC_LENDING remains fail-closed;
- an explicit canonical GENERAL assignment may remain available where genuinely reviewed/authorized;
- Program B / R6 remains the owner of actual K4 live scorer-adapter activation.

This means Program A may expand evidence without causing a legacy GENERAL numeric score to appear increasingly authoritative for a K4 company.

### Validation

Owner/Codex local validation reported:
- PKR-1 focused K3/K4/scoring/UI suite: 201 tests PASS;
- PKR-1 K-FINAL consolidated suite: 39 tests PASS;
- PKR-1B focused scoring/UI/K3/K4 suite: 95 tests PASS;
- PKR-1B K-FINAL including K5 isolation: 39 tests PASS;
- TypeScript = PASS;
- architecture guard = PASS;
- production build = PASS;
- TORNTPHARM golden control = PASS;
- AUROPHARMA fail-closed control = PASS;
- cross-sector isolation = PASS;
- universal Research workspace = PASS.

Known non-blocking repository debt:
- full-repository lint still contains 77 pre-existing errors outside PKR-1/PKR-1B;
- existing Vite chunk-size warning remains.

Safety unchanged:
- no provider calls;
- no production mutation/migration;
- no score/recommendation/sizing persistence activation;
- no scheduler activation;
- no AI activation;
- no portfolio mutation;
- no deployment;
- no PR merge;
- no automatic trading.

**PKR-1 / PKR-1B = COMPLETE / PASS / CLOSED.**

Program A remains NOT STARTED.

Next governance step:
- freeze PR #101 at this post-K reconciled state;
- choose a clean post-K Program A working branch from commit `f22b4efc8607102c51abadd46c62f362fd837084`;
- do not merge PR #101 without a separate explicit owner decision;
- Program A A1 must be planned/frozen before Codex implementation.


---

## Program A launch · A1 plan freeze — 23 September 2026

Clean Program A branch created:
- `program-a-evidence-coverage`;
- branched from reconciled post-K tip `239c209005b549ce4c6eff260d284091afe972fc`;
- PR #101 remains untouched / OPEN / DRAFT / UNMERGED.

Canonical A1 plan:
- `docs/PortfolioAI_PROGRAM_A_A1_EVIDENCE_BASELINE_AND_EXECUTION_PLAN.md`.

A1 title:
- **Read-only Evidence Baseline & Execution Contract Freeze**.

A1 purpose:
- establish current portfolio eligibility;
- produce cache-only R3 evidence coverage baseline;
- produce cache-only R5 market-history baseline;
- define pure incremental history-window planning;
- inventory benchmark dependencies;
- quantify projected provider work without executing it;
- propose bounded R3/R5 pilot cohorts for the next checkpoint.

Mandatory Codex behavior before build:
- read the canonical post-K plan, cumulative handoff, architecture audit, A1 plan, Integration & Execution Plan, Research & Intelligence Architecture and relevant current implementation;
- perform a bounded planning verification only;
- identify only hard contradictions, reuse points and minimal file-change set;
- STOP only for a genuine safety/architecture blocker;
- otherwise proceed directly into A1 implementation in the same Codex task;
- no open-ended re-audit cycle.

A1 explicitly prohibits:
- Trendlyne execution;
- Angel One execution;
- NSE/provider execution;
- production mutation/migration;
- score/recommendation/sizing persistence;
- scheduler activation;
- AI activation;
- portfolio mutation;
- deployment;
- PR merge;
- automatic trading.

Post-PKR scoring safety must remain:
- unsupported methodology → METHODOLOGY_NOT_AVAILABLE + BLOCKED;
- missing/conflicting classification → REVIEW_REQUIRED + BLOCKED;
- completed K4 methodology → AVAILABLE + scoring execution PENDING_ADAPTER;
- no legacy GENERAL numeric scoring for K4;
- PHARMA_V1 and supported BANK scoring preserved;
- NBFC_LENDING fail-closed.

**Program A = IN PROGRESS (planning started).**
**A1 plan = FROZEN / IMPLEMENTATION NOT STARTED.**
**Provider execution = NOT AUTHORIZED.**


---

## Program A · A1 implementation status — 23 September 2026

### A1.1 — Planner / contract implementation

Commit:
- `a8ed4867801abee34d3d9ab84c9cbdadbf5ad287`

Status:
- COMPLETE / PASS.

Implemented:
- Program A eligibility resolver;
- deterministic R3 evidence-coverage planner;
- deterministic R5 market-history planner;
- pure incremental-history window planning;
- benchmark dependency inventory;
- projected provider-cost planner;
- bounded pilot-cohort proposal;
- explicit zero-provider / zero-budget safety state.

Important architectural result:
- completed K4 methodologies remain `AVAILABLE + PENDING_ADAPTER`;
- no K4 engine falls through to legacy GENERAL numeric scoring;
- unsupported/review-required methodology stays fail-closed.

### A1.2 — Real cache-only baseline materializer

Commit:
- `3534c2b69ccb14d3c73d6437b9685882ba1a03e6`

Status:
- IMPLEMENTATION COMPLETE / PASS.

Implemented:
- cache-only snapshot SQL using `BEGIN TRANSACTION READ ONLY`;
- local-only execution guard restricted to localhost / 127.0.0.1 port 54322;
- materialization of current Portfolio Coverage Registry rows into `ProgramAHoldingInput[]`;
- canonical R3 materialization for fundamentals, ownership, ratings applicability/evidence, documents, valuation and honest durability-missing state;
- R5 materialization from Angel One mapping state, stored candle bounds and existing market metrics;
- runtime benchmark evidence only for implemented NIFTY_BANK / NIFTY_PHARMA support;
- deterministic JSON + CLI-safe Markdown report;
- local command `bash scripts/program-a-a1-materialize-local.sh <local-portfolio-uuid> [YYYY-MM-DD]`.

Validation reported:
- 47 focused tests PASS;
- K-FINAL consolidated 39 tests PASS;
- TypeScript PASS;
- architecture guard PASS;
- changed-file lint PASS;
- build PASS;
- existing chunk-size warning only.

Real local execution:
- successfully materialized the six-holding `LOCAL UI Research Review` portfolio;
- eligible = 1;
- review required = 5;
- projected Trendlyne calls = 2;
- projected Angel One security requests = 1;
- actual provider calls = 0;
- budget consumed = 0;
- writes = 0.

Observed data gaps from the local run:
- classification coverage incomplete for five of six holdings;
- canonical business-durability materialization unavailable;
- authoritative portfolio weight remains owned by the client read model and is not persisted in the local database snapshot.

Safety:
- no Trendlyne call;
- no Angel One call;
- no NSE/provider call;
- no production access;
- no migration;
- no score/recommendation/sizing persistence;
- no scheduler/AI activation;
- no deployment;
- no merge;
- no trading.

A1 engineering implementation is complete. Formal full-portfolio closure requires either:
1. running the same cache-only materializer against the owner's full current local portfolio dataset, if present locally; or
2. explicitly accepting the six-holding local portfolio as the A1 runtime validation cohort and carrying full-portfolio data coverage into the next Program A execution checkpoint.

No additional architecture work is required for A1.


---

## Program A · A1 formal closure — 23 September 2026

Local portfolio inventory check confirmed that the current local Supabase instance contains only the small UI/test portfolios:
- `10000000-0000-4000-8000-000000000001` — `LOCAL UI Research Review`;
- `a1000000-0000-4000-8000-000000000001` — `Local UI Review`.

No full owner portfolio dataset is presently available in local Supabase.

Therefore the already-successful six-holding `LOCAL UI Research Review` execution is accepted as the A1 runtime validation cohort.

Accepted runtime result:
- eligible = 1;
- review required = 5;
- projected Trendlyne calls = 2;
- projected Angel One security requests = 1;
- actual provider calls = 0;
- actual budget consumed = 0;
- writes = 0.

A1 acceptance interpretation:
- A1's purpose was to prove the real cache-only materialization path and quantify current coverage gaps without provider execution;
- that objective is satisfied;
- absence of the full current portfolio in local Supabase is an environment/data-availability issue, not an A1 architecture or implementation blocker;
- full-portfolio breadth will be handled by subsequent Program A execution checkpoints when the appropriate local/current portfolio scope is available.

Final status:
- A1.1 = COMPLETE / PASS;
- A1.2 = COMPLETE / PASS;
- **Program A · A1 = COMPLETE / PASS / CLOSED**;
- Program A = IN PROGRESS;
- provider execution = STILL NOT AUTHORIZED.

Next step:
- plan/freeze the first bounded provider-backed Program A execution checkpoint;
- no provider execution until that next checkpoint is explicitly approved.


---

## Program A · A2 plan freeze — 23 September 2026

Canonical plan:
- `docs/PortfolioAI_PROGRAM_A_A2_BOUNDED_PROVIDER_PILOT_PLAN.md`.

A2 title:
- **Prerequisite-First Bounded Provider Pilot**.

A2 is the first provider-backed Program A checkpoint, but provider execution remains gated behind an exact generated PLAN and explicit owner approval.

A1 local runtime evidence showed:
- six-holding validation cohort;
- eligible = 1;
- review required = 5;
- main immediate blocker = incomplete canonical classification.

Therefore A2 sequence is frozen as:
1. A2A classification prerequisite pilot for at most five review-blocked securities;
2. re-materialize the A1 baseline;
3. A2B bounded R3 evidence pilot for at most three eligible securities;
4. A2C bounded R5 Angel One history pilot for at most three eligible securities;
5. re-materialize and validate;
6. stop.

Hard ceilings:
- A2A Trendlyne classification calls <= 5;
- A2B Trendlyne physical calls <= 6;
- A2A + A2B Trendlyne physical calls <= 10;
- A2C Angel One security requests <= 3;
- A2C benchmark requests <= 2;
- total Angel One historical requests <= 5;
- retries count toward ceilings.

Mandatory execution contract:
- PLAN = zero provider calls;
- Codex may implement and run PLAN only;
- EXECUTE requires exact owner-approved confirmation after ChatGPT audits the generated plan;
- local Supabase only;
- production execution prohibited.

A2 implementation must reuse existing provider control plane, leases, freshness, retry/accounting and idempotent persistence rather than direct ad-hoc provider calls.

Safety unchanged:
- no score/recommendation/sizing activation;
- no scheduler change;
- no AI activation;
- no deployment;
- no PR merge;
- no automatic trading.

**Program A · A1 = COMPLETE / PASS / CLOSED.**
**Program A · A2 plan = FROZEN / IMPLEMENTATION NOT STARTED.**
**Provider execution = NOT AUTHORIZED.**


---

## Program A · A2 implementation checkpoint — 23 September 2026

Implementation commit:
- `94335ffcd561df3f292129156c3913322f5465e1`

Status:
- implementation = COMPLETE / PASS;
- provider execution = NOT YET RUN;
- A2 formal closure = PENDING owner-approved staged execution + validation.

Implemented:
- deterministic A2 PLAN builder with SHA-256 plan ID and exact confirmation token;
- exact bounded A2A classification cohort;
- bounded A2B Complete Research cohort;
- bounded A2C incremental Angel One history cohort;
- local-only guards in controller and A2-specific Edge Function paths;
- existing provider budgets, leases, accounting, lineage and idempotent persistence reused;
- stale-plan/cache-drift guard;
- runtime call ceilings;
- classification conflict / ambiguous identity hard stops;
- A1 incremental history window passed into existing Angel One history adapter;
- CLI with explicit PLAN / EXECUTE modes.

Audited current local PLAN:
- plan ID `cc238e54b2d904c4298b9cdb29f4d02f13067dc2787d289a859e4e5471d995a3`;
- A2A classification cohort: ALIVUS, AUROPHARMA, BIOCON, HDFCBANK, SYNGENE;
- A2B provisional cohort: TORNTPHARM via reviewed four-call Complete Research capability;
- A2C provisional cohort: TORNTPHARM incremental history, 2026-09-12 through 2026-09-23;
- projected Trendlyne total = 9;
- projected Angel One total in the generated local plan = 1;
- actual calls/budget = 0;
- confirmation token `APPROVE_PROGRAM_A_A2_CC238E54B2D904C4`.

Critical staged-execution behavior:
- after A2A classification writes, A2 re-materializes the cache and rebuilds the plan;
- any classification change alters the plan fingerprint;
- execution therefore stops before A2B with `STALE_PLAN_REPLAN_REQUIRED`;
- a new PLAN and a new explicit owner approval are required before A2B/A2C;
- this prevents one approval from silently expanding into deeper evidence/history execution after classification state changes.

Validation reported:
- 52 focused application tests PASS;
- 143 Edge/provider-control tests PASS;
- K-FINAL regressions PASS;
- TypeScript PASS;
- architecture guard PASS;
- changed-file lint PASS;
- build PASS;
- no provider contacted during implementation.

Safety unchanged:
- local Supabase only;
- no production mutation;
- no score/recommendation/sizing activation;
- no scheduler/AI activation;
- no deployment;
- no merge;
- no trading.

**A2 implementation = PASS / READY FOR OWNER REVIEW OF A2A EXECUTION.**


---

## Program A · A2A first-run rejection diagnosis and contract correction — 23 September 2026

The owner-approved V2 A2A run stopped on its first action, ALIVUS, after one
successful Trendlyne `search_entities` provider attempt. No classification source
record, observation or decision was written, and A2B/A2C did not run.

Correlated local append-only audit evidence:
- ingestion run `c9c24be1-09b3-4ced-a398-7172a7ff756b`;
- ALIVUS run item `975c2264-6c30-4ca1-9128-52f6c2697c10`;
- item status `REJECTED`;
- exact safe reason `NO_EXACT_PROVIDER_IDENTITY`;
- attempted calls = 1, accepted records = 0;
- provider usage event outcome = `SUCCEEDED`, proving the transport/tool call completed;
- no `data_source_records` row exists for the run and the item metadata is empty.

Therefore the incident was not proven ambiguous. The provider response produced
zero candidates satisfying both the exact canonical ALIVUS ISIN and exact symbol
contract. The earlier implementation did not retain safe candidate-count
diagnostics, so the historical evidence cannot distinguish no parsed candidates,
symbol-only matches, ISIN-only matches or other non-exact candidates. No repeat
provider call was made merely to diagnose that missing historical detail.

Focused correction:
- exact canonical-ISIN plus exact-symbol matching remains mandatory and fail-closed;
- no symbol/name similarity fallback was introduced;
- `NO_EXACT_PROVIDER_IDENTITY`, `AMBIGUOUS_PROVIDER_IDENTITY` and
  `CLASSIFICATION_MISSING` now remain distinct from Edge audit through the A2 runner;
- rejected items retain only non-secret aggregate match counts, never raw provider payloads;
- rejected-only ingestion runs finish `FAILED`, rather than misleadingly `SUCCEEDED`;
- arbitrary provider text is collapsed to a safe generic code;
- the A2 plan contract advances to V3, invalidating the previous V2 plan approval.

Validation:
- pure classification matcher/rejection-path tests = PASS;
- runner safe-code propagation and zero-write rejection tests = PASS;
- A2 controller fingerprint, local-target, budget and stage-boundary regressions = PASS;
- focused application regressions = 39 PASS;
- Edge/provider-control suite = 147 PASS;
- TypeScript, architecture guard, changed-file lint and production build = PASS;
- no live provider call was made by this correction.

Fresh zero-provider-call plan:
- version `PROGRAM_A_A2_BOUNDED_PILOT_V3`;
- plan ID `d0e5319836c579567f94cce1ad25c0485de77b0f9cc46a29d36d53f0545836de`;
- confirmation token `APPROVE_PROGRAM_A_A2_D0E5319836C57956`;
- exact A2A cohort remains ALIVUS, AUROPHARMA, BIOCON, HDFCBANK, SYNGENE;
- all five canonical ISIN prerequisites are `READY`;
- A2A Trendlyne ceiling = 5, actual PLAN calls/budget/writes = 0.

Remaining sequence:
1. generate and review a fresh zero-provider-call V3 PLAN;
2. obtain explicit owner approval for its exact plan ID/token;
3. run classification-only A2A;
4. verify local canonical writes and rematerialized A1 baseline;
5. require `STALE_PLAN_REPLAN_REQUIRED` before any A2B/A2C execution.

**Program A · A2 remains IN PROGRESS.**
**The prior V2 plan approval must not be reused.**

---

## Program A · A2A V3 safe-shape diagnosis and V4 replan — 23 September 2026

The owner-executed V3 A2A attempt again stopped on ALIVUS after one successful
Trendlyne tool attempt and before any local classification write. A2B and A2C did
not run.

Correlated local audit evidence:
- ingestion run `8adbb1bb-213e-431b-b310-7b91928934e4`;
- ALIVUS run item `ae073f41-3492-4228-b1b5-82374114e19b`;
- run status `FAILED`, attempted = 1, accepted = 0, rejected = 1, failed = 0;
- item status `REJECTED`, safe reason `NO_EXACT_PROVIDER_IDENTITY`, attempted calls = 1, accepted records = 0;
- safe item counts: candidates = 0, symbol matches = 0, ISIN matches = 0,
  exact matches = 0, classified exact matches = 0.

This audit inspection made zero provider calls and no writes. The V3 metadata
proved that the parser produced no candidates, but it could not distinguish a
valid empty provider table from an unrecognized response envelope or table shape.
Raw provider content was not retained, so the historical V3 response cannot be
reconstructed and no unsupported claim about Trendlyne identity data is made.

Focused V4 correction:
- recognizes the reviewed marked table, plain Markdown pipe tables, compact pipe
  delimiters, and JSON string envelopes under `markdown_data`, `result`, or `data`;
- locates required fields by normalized header name instead of fixed column offset;
- preserves exact canonical symbol plus exact canonical ISIN matching;
- records only safe parse-shape metadata: parse state, envelope class, marker
  presence, nonempty-line count, pipe-line count and parsed-row count;
- distinguishes valid empty results from nonempty unrecognized response shapes;
- rejects an unrecognized shape as `PROVIDER_SCHEMA_MISMATCH`, with zero writes;
- retains `NO_EXACT_PROVIDER_IDENTITY` for a successfully parsed table with no
  exact candidate and retains all other distinct rejection reasons;
- advances the plan contract to V4, invalidating the V3 plan approval.

Validation:
- Edge/provider-control suite = 150 PASS;
- focused A1/A2 application regressions = 20 PASS;
- runner safe-code propagation suite = 6 PASS;
- TypeScript and architecture guard = PASS;
- PLAN generation made zero provider calls and consumed zero provider budget.

Fresh zero-provider-call V4 plan:
- version `PROGRAM_A_A2_BOUNDED_PILOT_V4`;
- plan ID `c35d2b1c8d39c6ea7c065fc3dfa63f4f56e2c4a95cb581e5e024a7342197c29e`;
- confirmation token `APPROVE_PROGRAM_A_A2_C35D2B1C8D39C6EA`;
- exact A2A cohort remains ALIVUS, AUROPHARMA, BIOCON, HDFCBANK, SYNGENE;
- all five canonical identity prerequisites are `READY`;
- HDFCBANK uses canonical local ISIN `INE040A01034`;
- A2A Trendlyne ceiling = 5; total planned Trendlyne = 9; Angel One = 1;
- actual PLAN provider calls, budget consumed and writes = 0.

Remaining sequence:
1. review and explicitly approve the exact V4 plan ID/token;
2. run classification-only A2A;
3. inspect the first item safe counts and new parse-shape metadata;
4. verify any accepted local canonical writes and rematerialized A1 baseline;
5. require `STALE_PLAN_REPLAN_REQUIRED` before any A2B/A2C execution.

**Program A · A2 remains IN PROGRESS.**
**No V2 or V3 approval may be reused.**

---

## Program A · A2A V4 execution result — 23 September 2026

The owner explicitly approved V4 plan
`c35d2b1c8d39c6ea7c065fc3dfa63f4f56e2c4a95cb581e5e024a7342197c29e`
and its exact confirmation token. The first invocation stopped before dispatch
because the runner process lacked its three required local environment variables;
that invocation made zero provider calls. The same approved plan was then invoked
with credentials resolved only from the running local Supabase instance and local
Vault, without printing or persisting them.

Bounded execution result:
- status `PARTIAL_STOPPED`;
- stop reason `PROVIDER_SCHEMA_MISMATCH`;
- Trendlyne calls = 1; Angel One calls = 0; retries = 0;
- successful local classification writes = 0;
- score, recommendation and sizing writes = 0;
- A2B and A2C did not execute.

Correlated local audit evidence:
- ingestion run `f38aa9e7-5cdc-4062-b71f-05810cf6609e`;
- ALIVUS item `f2eba073-3b49-4b1e-a542-d464596d22e5`;
- run status `FAILED`, attempted = 1, accepted = 0, rejected = 1, failed = 0;
- item status `REJECTED`, safe reason `PROVIDER_SCHEMA_MISMATCH`;
- provider usage outcome `SUCCEEDED`, retry attempt = 0, internal units = 1;
- source records written for this run = 0;
- safe parse shape: `UNRECOGNIZED_RESPONSE`, envelope `PLAIN_TEXT`, data marker
  present, end marker absent, nonempty lines = 1, pipe-delimited lines = 0,
  parsed candidate rows = 0.

Conclusion:
- this is not evidence of an ambiguous identity or of no exact ALIVUS identity;
- Trendlyne returned a successful nonempty one-line response whose shape is not
  recognized by the approved parser;
- raw provider content was deliberately not retained, so its schema cannot be
  reconstructed from this audit and must not be guessed;
- existing local K1 evidence shows Trendlyne has previously returned nested
  `markdown_data` and non-header pipe data for a different capture, but that does
  not prove the V4 ALIVUS response used the same schema.

The V4 approval is consumed and must not be reused. Before another provider call,
the response contract must be established through provider capability/schema
evidence or a newly reviewed safe diagnostic plan. A fresh fingerprinted plan and
explicit owner approval are required.

**Program A · A2 remains IN PROGRESS at A2A.**
**A2B and A2C remain blocked by the classification stage boundary.**
